CClinicalTrials.gg
CompletedNCT02707549Updated Nov 14, 2017

Fluid Therapy During Brain Tumor Resection in Children

A Phase 2 interventional study of balanced crystalloid solution (components: sodium chloride, sodium gluconate, sodium acetate, potassium chloride and magnesium chloride) and 0.9% sodium chloride in Brain Neoplasms, sponsored by Federal University of São Paulo. Completed at 1 site in Brazil. Open to participants aged 6 Months to 12 Years. Per ClinicalTrials.gov, last updated 2017-11-14.

Sponsored by Federal University of São Paulo · Phase 2, Interventional, and Treatment

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Aug 2015, registered Mar 2016).
Phase
Phase 2
Study type
Interventional
Enrollment
53
Allocation
Randomized
Ages
6 Months to 12 Years
Sex
All
01

Study summary

Fluid management of children during neurosurgery is not well established. Hypotonic solutions, commonly still used in pediatric patients, may enhance cerebral edema and worse operative conditions. This study compares two different isotonic solutions administered perioperatively regarding acid base and fluid electrolyte disturbances.

02

Conditions studied

  • Brain Neoplasms

Browse trials for

Keywords

  • crystalloid solutions
  • acid-base imbalance
  • water-electrolyte Imbalance
03

In context

Brain Neoplasms

1,960 studies on the registry are indexed under Brain Neoplasms; 516 are open to participants now.

This study's enrollment of 53 is above the median of 40 across 1,458 interventional studies indexed under Brain Neoplasms.

Browse Brain Neoplasms studies →

Lead sponsor

Federal University of São Paulo is the lead sponsor of 427 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Months to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Children undergoing elective craniotomy for brain tumor resection
  • Informed consent form signed and dated by legal guardian and investigator
  • Informed assent form signed by the patient if appropriate

Exclusion criteria

Exclusion Criteria:

  • Uncontrolled Intracranial hypertension
  • Severe heart, kidney, or pulmonary disease
  • non-corrected electrolyte imbalance
  • allergy to the solution administered
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
53 participants (actual)

Study arms

  • Active comparator
    Normal Saline Group

    the patients included in this group will receive normal saline solution (0.9% sodium chloride) during surgery and in the first 24 hours after ICU admission.

    Drug: 0.9% sodium chloride

  • Experimental
    Balanced Crystalloid Solution Group

    the patients included in this group will receive balanced crystalloid solution during surgery and in the first 24 hours after ICU admission.

    Drug: balanced crystalloid solution (components: sodium chloride, sodium gluconate, sodium acetate, potassium chloride and magnesium chloride)

Interventions

  • Drugbalanced crystalloid solution (components: sodium chloride, sodium gluconate, sodium acetate, potassium chloride and magnesium chloride)
  • Drug0.9% sodium chloride
06

What researchers measure

Primary outcomes

  1. serum chloride difference (mmol/L)

    Serum chloride will be collected in two different moments: right before the beginning of the surgery and right after de end of the procedure. We will calculate the difference between the two values.

    Time frame: from the admission of the patient in the operating room until the end of the surgery.

Secondary outcomes

  1. serum chloride difference (mmol/L)

    Serum chloride will be collected right after the end of the surgery as well as 24 hours after the admission in ICU. We will calculate the difference between the two values.

    Time frame: from the end of the surgery until exactly 24 hours after the admission in intensive care unit (ICU)

  2. brain relaxation score

    Time frame: immediately after dura-mater opening

  3. serum sodium difference (mmol/L)

    Serum sodium will be collected in two different moments: right before the beginning of the surgery and right after de end of the procedure. We will calculate the difference between the two values.

    Time frame: from the admission of the patient in the operating room until the end of the surgery.

07

Study locations

1 site
  • Federal University of Sao Paulo
    Sao Paulo, SP 04023-062, Brazil
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 14, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02707549
Lead sponsor
Federal University of São Paulo
Responsible party
Mariana Fontes Lima Neville (Principal Investigator, Federal University of São Paulo) — Principal investigator
First posted
Mar 14, 2016
Start date
Aug 2015
Primary completion
Dec 2016
Completion
Jun 2017
Last update
Nov 14, 2017

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion